1. Home
  2. IPW vs AKTX Comparison

IPW vs AKTX Comparison

Compare IPW & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iPower Inc.

IPW

iPower Inc.

HOLD

Current Price

$10.09

Market Cap

13.1M

ML Signal

HOLD

Logo Akari Therapeutics plc ADS

AKTX

Akari Therapeutics plc ADS

HOLD

Current Price

$0.39

Market Cap

14.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPW
AKTX
Founded
2018
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
14.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IPW
AKTX
Price
$10.09
$0.39
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.30
AVG Volume (30 Days)
25.4K
1.3M
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$59,151,725.00
N/A
Revenue This Year
$149.67
N/A
Revenue Next Year
$15.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.43
$0.26
52 Week High
$34.65
$1.73

Technical Indicators

Market Signals
Indicator
IPW
AKTX
Relative Strength Index (RSI) 50.50 37.50
Support Level $10.21 $0.26
Resistance Level $12.13 $0.36
Average True Range (ATR) 1.32 0.07
MACD -0.13 0.00
Stochastic Oscillator 28.19 37.65

Price Performance

Historical Comparison
IPW
AKTX

About IPW iPower Inc.

iPower Inc is a United States-based online retailer and supplier of consumer home, pet, garden, outdoor, and consumer electronics products. It also operates as a provider of value-added ecommerce services for third-party products and brands. The company's capabilities include a spectrum of online channels, fulfillment capacity, a network of warehouses serving the U.S., last-mile delivery partners, and a differentiated business intelligence platform. The company's sales channels currently include Amazon Vendor, Amazon 3P, Walmart.com, TikTok, Temu, and other marketplaces, as well as its own e-commerce websites, such as simpledeluxe.com and more. Additionally, it is developing in-house branded products and through supply chain partners, which include iPower, Simple Deluxe, and other brands.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

Share on Social Networks: